REBOOT #511 Alzheimer's Disease: Updates in Diagnosis and Treatment

About this episode

Blood-based Biomarkers, Anti-Amyloid Therapies and Beyond We have another classic episode for you. From blood-based biomarkers to anti-amyloid treatments, join us as we explore the latest in Alzheimer’s disease diagnosis and treatment with Dr. Halima Amjad. This episode will equip you to guide your patients about the latest Alzheimer’s diagnostics as well as eligibility, risks and monitoring for anti-amyloid therapies. Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments • Intro • Case • Cognitive and functional history reminders • Diagnosing Alzheimer’s Disease • Blood-based biomarkers • Anti-amyloid therapy indications, eligibility and contraindications • Patient counseling and treatment decisions • ARIA • Key takeaways • Outro Credits • Written and Produced by: Natalie Barrett DO, Rachel K Miller MD • Show notes, cover art and infographic: Natalie Barrett DO, Rachel K Miller MD, Leah Witt MD • Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    • Reviewer: Sai S Achi MD, MBA,FACP • Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP • T